Shanghai Runda Medical Technology Co., Ltd. - Laporan Laba Rugi (TTM)

Shanghai Runda Medical Technology Co., Ltd.
CN ˙ SHSE
CN¥ 17.06 ↑0.30 (1.79%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shanghai Runda Medical Technology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 6,784 7,069 7,790 8,369 8,784 8,860 9,008 9,378 9,854 10,494 10,504 10,255 9,751 9,147 9,042 8,761 8,433 8,312 7,901 7,647
Change (%) 4.20 10.20 7.43 4.96 0.87 1.67 4.10 5.08 6.49 0.09 -2.37 -4.92 -6.19 -1.15 -3.10 -3.74 -1.44 -4.94 -3.22
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 4,988 5,158 5,654 6,059 6,391 6,468 6,590 6,910 7,206 7,564 7,531 7,302 7,036 6,731 6,658 6,443 6,212 6,211 6,010 5,940
Change (%) 3.41 9.62 7.16 5.47 1.21 1.88 4.86 4.28 4.96 -0.43 -3.04 -3.64 -4.33 -1.09 -3.24 -3.58 -0.02 -3.23 -1.17
% of Revenue 73.52 72.97 72.58 72.40 72.75 73.00 73.16 73.69 73.12 72.07 71.70 71.21 72.16 73.59 73.64 73.53 73.66 74.72 76.06 77.67
Gross Operating Profit 1,796 1,911 2,136 2,310 2,393 2,392 2,418 2,468 2,648 2,931 2,973 2,953 2,715 2,416 2,384 2,319 2,222 2,101 1,891 1,707
Change (%) 6.40 11.77 8.15 3.60 -0.06 1.10 2.04 7.33 10.66 1.44 -0.67 -8.06 -11.00 -1.33 -2.73 -4.19 -5.42 -10.00 -9.72
% of Revenue 26.48 27.03 27.42 27.60 27.25 27.00 26.84 26.31 26.88 27.93 28.30 28.79 27.84 26.41 26.36 26.47 26.34 25.28 23.94 22.33
SG&A 1,016 1,066 1,166 1,264 1,325 1,295 1,371 1,402 1,512 1,776 1,764 1,790 1,728 1,508 1,544 1,516 1,518 1,388 1,333 1,298
Change (%) 4.95 9.37 8.43 4.82 -2.25 5.82 2.30 7.80 17.52 -0.72 1.49 -3.46 -12.72 2.35 -1.81 0.12 -8.55 -3.96 -2.64
% of Revenue 14.97 15.08 14.97 15.10 15.09 14.62 15.22 14.95 15.34 16.93 16.79 17.45 17.72 16.49 17.07 17.30 18.00 16.70 16.87 16.97
R&D 78 87 99 105 113 123 127 130 141 146 147 153 149 147 144 138 125 116 113 115
Change (%) 11.96 13.25 6.27 7.58 8.81 3.29 2.83 8.28 3.60 0.83 3.91 -2.83 -1.16 -2.43 -4.06 -9.07 -7.25 -2.85 1.77
% of Revenue 1.15 1.23 1.27 1.25 1.28 1.38 1.41 1.39 1.43 1.39 1.40 1.49 1.53 1.61 1.59 1.57 1.49 1.40 1.43 1.50
OpEx 6,098 6,333 6,943 7,455 7,860 7,911 8,115 8,470 8,872 9,516 9,468 9,269 8,947 8,434 8,395 8,144 7,899 7,756 7,490 7,375
Change (%) 3.86 9.64 7.36 5.44 0.65 2.58 4.37 4.74 7.27 -0.50 -2.10 -3.48 -5.74 -0.45 -2.99 -3.01 -1.82 -3.43 -1.54
% of Revenue 89.88 89.58 89.13 89.07 89.48 89.29 90.09 90.32 90.03 90.68 90.14 90.39 91.76 92.20 92.85 92.96 93.67 93.31 94.80 96.44
Operating Income 686 736 847 914 924 949 893 908 983 978 1,036 985 804 714 646 617 534 556 411 272
Change (%) 7.26 15.03 7.97 1.03 2.74 -5.91 1.64 8.29 -0.48 5.88 -4.86 -18.44 -11.21 -9.43 -4.51 -13.44 4.11 -26.06 -33.82
% of Revenue 10.12 10.42 10.87 10.93 10.52 10.71 9.91 9.68 9.97 9.32 9.86 9.61 8.24 7.80 7.15 7.04 6.33 6.69 5.20 3.56
Interest Expense -254 -244 -260 -267 -272 -282 -288 -299 -304 -318 -330 -334 -335 -334 -331 -329 -320 -313 -300 -292
Change (%) -4.11 6.66 2.55 2.06 3.50 2.21 3.78 1.78 4.45 3.84 1.24 0.20 -0.25 -0.90 -0.61 -2.81 -2.16 -4.15 -2.48
% of Revenue -3.75 -3.45 -3.34 -3.19 -3.10 -3.18 -3.20 -3.19 -3.09 -3.03 -3.14 -3.26 -3.43 -3.65 -3.66 -3.76 -3.79 -3.76 -3.80 -3.82
Net Income 253 330 388 422 416 380 332 336 365 418 457 433 395 273 215 190 40 55 -37 -157
Change (%) 30.26 17.60 8.83 -1.51 -8.58 -12.74 1.34 8.41 14.60 9.51 -5.31 -8.78 -30.84 -21.38 -11.75 -78.76 37.28 -166.17 328.29
% of Revenue 3.73 4.67 4.98 5.05 4.74 4.29 3.68 3.59 3.70 3.98 4.36 4.22 4.05 2.99 2.38 2.16 0.48 0.67 -0.46 -2.05

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista